Gene · 2549
Papers2,374
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,374
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Crizotinib Has Preclinical Efficacy in Philadelphia-Negative Myeloproliferative Neoplasms. | Clin Cancer Res | 2023 | 36537918 | PubTator, text mining | PubMed |
| Glioblastoma stem cells express non-canonical proteins and exclusive mesenchymal-like or non-mesenchymal-like protein signatures. | Mol Oncol | 2023 | 36495079 | PubTator, text mining | PubMed |
| Viral miRNA regulation of host gene expression. | Semin Cell Dev Biol | 2023 | 36463091 | PubTator, text mining | PubMed |
| Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification. | Acta Neuropathol | 2023 | 36437415 | PubTator, text mining | PubMed |
| MET kinase inhibitor reverses resistance to entrectinib induced by hepatocyte growth factor in tumors with NTRK1 or ROS1 rearrangements. | Cancer Med | 2023 | 36416133 | PubTator, text mining | PubMed |
| Systematic pharmacological analysis of agonistic and antagonistic fibroblast growth factor receptor 1 MAbs reveals a similar unique mode of action. | J Biol Chem | 2023 | 36410439 | PubTator, text mining | PubMed |
| Research progress on the therapeutic effect and mechanism of metformin for lung cancer (Review). | Oncol Rep | 2023 | 36367180 | PubTator, text mining | PubMed |
| MicroRNAs and long non-coding RNAs in pancreatic cancer: From epigenetics to potential clinical applications. | Transl Oncol | 2023 | 36332600 | PubTator, text mining | PubMed |
| Proteomics reveals antiviral host response and NETosis during acute COVID-19 in high-risk patients. | Biochim Biophys Acta Mol Basis Dis | 2023 | 36328146 | PubTator, text mining | PubMed |
| Targeting RAS mutants in malignancies: successes, failures, and reasons for hope. | Cancer Commun (Lond) | 2023 | 36316602 | PubTator, text mining | PubMed |
| Proteomic time course of breast cancer cells highlights enhanced sensitivity to Stat3 and Src inhibitors prior to endocrine resistance development. | Cancer Gene Ther | 2023 | 36266450 | PubTator, text mining | PubMed |
| ZD6474 attenuates TGF-β1-induced fibrosis in human Tenon fibroblasts and inhibits neovascularization via AKT-mTOR signaling pathway. | Int Ophthalmol | 2023 | 36227401 | PubTator, text mining | PubMed |
| The comparison of differentially expressed microRNAs in Bag-1 deficient and wild type MCF-7 breast cancer cells by small RNA sequencing. | Turk J Biol | 2022 | 37533517 | PubTator, text mining | PubMed |
| Screening of autoantibodies as biomarkers in the serum of renal cancer patients based on human proteome microarray. | Acta Biochim Biophys Sin (Shanghai) | 2022 | 36789694 | PubTator, text mining | PubMed |
| Case report: Somatic mutations in microtubule dynamics-associated genes in patients with WNT-medulloblastoma tumors. | Front Oncol | 2022 | 36713498 | PubTator, text mining | PubMed |
| Multiple-model machine learning identifies potential functional genes in dilated cardiomyopathy. | Front Cardiovasc Med | 2022 | 36712235 | PubTator, text mining | PubMed |
| Crosstalk between protein kinases AKT and ERK1/2 in human lung tumor-derived cell models. | Front Oncol | 2022 | 36686779 | PubTator, text mining | PubMed |
| The Common Single Cause of Chronic Multi-Hormonal Resistance in Oxidative Stress. | Antioxidants (Basel) | 2022 | 36670938 | PubTator, text mining | PubMed |
| Gab1 regulates invadopodia and autocrine VEGF through SHP2/ERK1/2 in hilar cholangiocarcinoma cells. | Am J Transl Res | 2022 | 36628230 | PubTator, text mining | PubMed |
| From targeted therapy to a novel way: Immunogenic cell death in lung cancer. | Front Med (Lausanne) | 2022 | 36619616 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2549/papers?page=14